Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Universidade Federal do Triângulo Mineiro

ClinicalTrials.gov lists Universidade Federal do Triângulo Mineiro as lead sponsor of 12 trials.

BR Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

3 0 2012 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Universidade Federal do Triângulo Mineiro: 12 lead-sponsored trials and 1 legal-entity registration.

Get the Universidade Federal do Triângulo Mineiro report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (14)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 4
Disease 2
Obesity 2
Anxiety Disorders 1
Back Pain 1

Trials by start year as sponsor or collaborator (10)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 1
2025 1
2024 2
2023 1
2022 1
2019 2
2018 2
2015 3
2014 3
2012 1

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Journals published in (97)

Shown in this order: most published in first.

Journals published in
Journal Publications
Medicine and science in sports and exercise 12
Journal of applied physiology (Bethesda, Md. : 1985) 5
Journal of strength and conditioning research 5
Age and ageing 4
European journal of applied physiology 4

Latest dated events (17)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-05-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-05-28 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-03-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarkers this organization publishes on (43)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
IL6 4
CXCL8 3
IL10 3
IL17A 3
TNF 3

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarker capability evidence.